Welcome to our dedicated page for Black Hawk Acquisition Corporation news (Ticker: bkhau), a resource for investors and traders seeking the latest updates and insights on Black Hawk Acquisition Corporation stock.
Black Hawk Acquisition Corporation (BKHAU) is a blank check company focused on identifying strategic mergers and business combinations across industries. This news hub provides investors with centralized access to press releases, regulatory filings, and market developments related to BKHAU's SPAC operations.
Key updates include: merger announcements, acquisition targets, leadership changes, and filings with regulatory bodies. Our coverage emphasizes factual reporting on BKHAU's progress in evaluating potential partnerships while maintaining compliance with SPAC governance standards.
Bookmark this page for real-time updates on business combination agreements, investor communications, and strategic initiatives. Check regularly for essential information about BKHAU's market positioning as it works to complete a value-creating transaction.
Vesicor Therapeutics and Black Hawk Acquisition have signed a business combination agreement to create a biotechnology company focused on p53-based cancer therapeutics. The deal values Vesicor at $70 million pre-money equity value and is expected to complete in Q4 2025.
Founded in 2008 by Dr. Luo Feng, Vesicor's main product candidate is ecm-RV/p53, a genetically engineered microvesicle loaded with p53 mRNA. While unapproved in the US and Japan, the drug has been administered to patients with advanced breast, pancreatic, prostate, lung, and colorectal cancer in Tokyo since 2018 under Japan's Advanced Medical Care B program.
Key transaction points:
- Vesicor will become a wholly-owned subsidiary of Black Hawk
- Existing shareholders will roll over 100% of their equity
- Six-month lock-up period for certain shareholders
- Combined company will be listed on Nasdaq
Vesicor plans to begin US preclinical testing and submit an FDA investigational new drug application in 2026.
FAQ
What is the current stock price of Black Hawk Acquisition Corporation (bkhau)?
